Explore the full insider trade history of NorthStar Healthcare Income, Inc., a publicly traded company based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, NorthStar Healthcare Income, Inc. has recorded 11 public disclosures. The latest transaction was disclosed on 1 July 2022 — Don. Among the most active insiders: Carnella Jonathan A.. The full history is free.
11 of 11 declarations
NorthStar Healthcare Income, Inc. is a United States company historically listed in the NYSE/NASDAQ universe and structured as a healthcare-focused REIT. According to its SEC filings, the company was formed in October 2010 as a Maryland corporation and commenced operations in February 2013. Its business model is centered on owning a diversified portfolio of seniors housing properties across the United States, including independent living facilities, assisted living facilities, and memory care facilities. In practical terms, NorthStar Healthcare is not a medical-device, biotech, or drug-development company; it is a real estate owner/investor leveraged to the structural demand created by an aging population and the need for senior housing. From a historical perspective, the company was built as a healthcare real estate investment platform with a clear focus on the senior housing segment. Its early disclosures show an emphasis on acquiring and managing healthcare real estate assets, particularly in the mid-acuity senior housing space and private-pay oriented properties. That positioning matters because private-pay senior housing tends to be less directly tied to government reimbursement and more dependent on occupancy, local demand, operator execution, and asset quality. Over time, NorthStar Healthcare used public capital raises and portfolio investments to broaden and diversify its U.S. footprint. Operationally, the company’s core business lines are asset ownership, portfolio management, and capital allocation within the senior housing category. Its competitive position is therefore shaped by the strength of its portfolio composition, the geographic distribution of its properties, the performance of operating partners, and the ability to preserve cash flow in a challenging healthcare real estate environment. Relative to larger healthcare REIT peers, NorthStar Healthcare was a more specialized platform, which can be a strength in terms of focus but also a limitation in terms of scale, liquidity, and diversification. The most important recent development is strategic rather than operational: on January 29, 2025, NorthStar Healthcare announced a definitive merger agreement under which an affiliate of Welltower agreed to acquire the company for $3.03 per share in cash, implying an enterprise value of roughly $900 million, subject to customary closing conditions and stockholder approval. That announcement is central to the current investment case and suggests the equity may be in a late-stage corporate event rather than a standalone growth story. For investors, the key questions are now deal completion, timing, and realized value versus the announced consideration. Overall, NorthStar Healthcare should be viewed as a U.S. senior housing REIT with an event-driven profile rather than a long-duration operating compounder.